Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin

• Prif Awduron: Fernando Pascual (Awdur), Carmen Au (Awdur), Chido Dziva Chikwari (Awdur), Pierre Daram (Awdur), Carolyn Deal (Awdur), Angelica Espinosa Miranda (Awdur), Yonatan H. Grad (Awdur), Edward WIII Hook (Awdur), Rossaphorn Kittiyaowamarn (Awdur), Alison Luckey (Awdur), Nicola Low (Awdur), Venessa Maseko (Awdur), Remco P. H. Peters (Awdur), Teri Roberts (Awdur), Magnus Unemo (Awdur), Subasree Srinivasan (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2024-09-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract New, first-in-class oral antibiotics like zoliflodacin, developed in a public-private partnership, require an optimal introduction strategy while ensuring antibiotic stewardship. Zoliflodacin, given as a single dose for uncomplicated urogenital gonorrhoea, recently demonstrated non-inferior...